Black Rock Inc. Neogenomics Inc Transaction History
Black Rock Inc.
- $4.23 Trillion
- Q1 2024
A detailed history of Black Rock Inc. transactions in Neogenomics Inc stock. As of the latest transaction made, Black Rock Inc. holds 19,850,864 shares of NEO stock, worth $272 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
19,850,864
Previous 19,980,993
0.65%
Holding current value
$272 Million
Previous $323 Million
3.48%
% of portfolio
0.01%
Previous 0.01%
Shares
12 transactions
Others Institutions Holding NEO
# of Institutions
279Shares Held
127MCall Options Held
1.13MPut Options Held
232K-
Vanguard Group Inc Valley Forge, PA14.2MShares$195 Million0.0% of portfolio
-
Brown Advisory Inc9.67MShares$133 Million0.21% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.86MShares$94 Million0.07% of portfolio
-
Janus Henderson Group PLC London, X06.28MShares$86.1 Million0.06% of portfolio
-
State Street Corp Boston, MA4.9MShares$67.1 Million0.0% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.72B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...